Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial-Reference-Cited by-同舟云学术

Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial

Published:2022-09 Issue:3 Volume:166 Page:494-502
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Chase Dana M.,Marín Margarita Romeo,Backes Floor,Han Sileny,Graybill Whitney,Mirza Mansoor Raza,Pothuri Bhavana,Mangili Giorgia,O'Malley David M.,Berton Dominique,Willmott Lyndsay,Baumann Klaus,Coleman Robert L.,Safra Tamar,Heinzelmann-Schwarz Viola,Lorusso Domenica,Karl Florian M.,Woodward Tatia,Monk Bradley J.,Gonzalez-Martin Antonio

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference21 articles.

1. Ovarian cancer: an integrated review;Stewart;Semin. Oncol. Nurs.,2019

2. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy

3. Health-related quality of life in ovarian cancer patients and its impact on clinical management;Chase;Expert. Rev. Pharmacoecon. Outcomes Res.,2011

4. Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial;Friedlander;Lancet Oncol.,2021

5. Impact of recurrence of ovarian cancer on quality of life and outlook for the future;Colombo;Int. J. Gynecol. Cancer,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from PRIMA/ENGOT-OV26/GOG-3012 trial;Annals of Oncology;2024-09

2. First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature;Clinical and Translational Oncology;2024-07-19

3. Predictors of quality of life and resilience in patients with ovarian cancer during the COVID-19 pandemic: a cross-sectional study;2024-04-24

4. Systematic Review of the Literature on Multiple Co-occurring Symptoms in Patients Receiving Treatment for Gynecologic Cancers;Seminars in Oncology Nursing;2024-02

5. Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients;Quality of Life Research;2024-01-19